Bionano Genomics Inc (NASDAQ:BNGO)

0.618
Delayed Data
As of Sep 17
 +0.0399 / +6.76%
Today’s Change
0.25
Today|||52-Week Range
4.70
-50.16%
Year-to-Date
Bionano Genomics: Intriguing Technology. Troubling Trajectory
Sep 08 / Seeking Alpha - Paid Partner Content
Bionano Saphyr’s enters clinical laboratory for genome imaging
Aug 20 / Seeking Alpha - Paid Partner Content
Bionano Genomics names new finance executive
Aug 26 / Seeking Alpha - Paid Partner Content
Bionano's Saphyr enters clinical laboratory for genome imaging
Aug 20 / Seeking Alpha - Paid Partner Content
Bionano Genomics acquires Lineagen for ~$9.6M
Aug 24 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close0.59
Today’s open0.57
Day’s range0.57 - 0.64
Volume11,018,847
Average volume (3 months)19,435,201
Market cap$108.0M
Data as of 3:59pm ET, 09/17/2020

Growth & Valuation

Earnings growth (last year)+23.84%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-15.59%
P/E ratioNM
Price/Sales1.83
Price/Book7.40

Competitors

 Today’s
change
Today’s
% change
XXII22nd Century Group I...+0.00+0.46%
GNCAGenocea Biosciences ...-0.20-7.30%
ETTXEntasis Therapeutics...+0.01+0.34%
IMMPImmutep Ltd0.000.00%
Data as of 6:37pm ET, 09/17/2020

Financials

Next reporting dateNovember 4, 2020
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$10.1M
Annual profit (last year)-$29.8M
Net profit margin-294.34%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts